{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:00:49Z","timestamp":1786374049663,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf00800674","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T01:32:59Z","timestamp":1102987979000},"page":"190-197","source":"Crossref","is-referenced-by-count":40,"title":["New antiarrhythmic drugs in pediatric use: Propafenone"],"prefix":"10.1007","volume":"15","author":[{"given":"T.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Janousek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"20D","DOI":"10.1016\/S0002-9149(84)80280-5","volume":"54","author":"BJ Baker","year":"1984","unstructured":"Baker BJ, Dinh H, Kroskey D, et al. (1984) Effect of propafenone on left ventricular ejection fraction.Am J Cardiol 54:20D-22D","journal-title":"Am J Cardiol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/clpt.1983.55","volume":"33","author":"GG Belz","year":"1983","unstructured":"Belz GG, Doering W, Munkes R, Mathews J (1983) Interaction between digoxin and calcium antagonists and antiarhythmic drugs.Clin Pharmacol Ther 33:410?417","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"29D","DOI":"10.1016\/S0002-9149(84)80283-0","volume":"54","author":"G Breithardt","year":"1984","unstructured":"Breithardt G, Borgrefe M, Wiebringhaus E, Seipel L (1984) Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.Am J Cardiol 54:29D-39D","journal-title":"Am J Cardiol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-8703(85)90459-4","volume":"110","author":"MA Brodsky","year":"1985","unstructured":"Brodsky MA, Allen BJ, Abate D, Henry WL (1985) Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.Am Heart J 110:794?799","journal-title":"Am Heart J"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/oxfordjournals.eurheartj.a061881","volume":"6","author":"J Buss","year":"1985","unstructured":"Buss J, Neuss H, Bilgin Y, Schlepper M (1985) Malignant ventricular tachyarrhythmias in association with propafenone treatment.Eur Heart J 6:424?428","journal-title":"Eur Heart J"},{"issue":"Suppl III","key":"CR6","first-page":"III","volume":"82","author":"CL Case","year":"1990","unstructured":"Case CL, Ravin RR, Hewett KW, Gillette PC, Maheshwari R (1990) Developmental effects of propafenone and its major metabolite on abnormal automaticity.Circulation 82 (Suppl III): III-224 [abstract]","journal-title":"Circulation"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/clpt.1984.157","volume":"36","author":"S Conolly","year":"1984","unstructured":"Conolly S, Lebsack C, Winkle RA, Harrison DC, Kates RE (1984) Propafenone disposition kinetics in cardiac arrhythmia.Clin Pharmacol Ther 36:163?168","journal-title":"Clin Pharmacol Ther"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.68.3.589","volume":"68","author":"SJ Conolly","year":"1983","unstructured":"Conolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA (1983) Clinical pharmacology of propafenone.Circulartion 68:589?596","journal-title":"Circulartion"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1016\/S0002-9149(84)80288-X","volume":"54","author":"P Coumel","year":"1984","unstructured":"Coumel P, Leclerq JF, Assayag P (1984) European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.Am J Cardiol 54:60D-66D","journal-title":"Am J Cardiol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1476-5381.1985.tb11098.x","volume":"86","author":"C Delgado","year":"1985","unstructured":"Delgado C, Tamargo J, Tejerina T (1985) Electrophysiological effects of propafenone in untreated and propafenone-pretreated guine-pig and ventricular muscle fibres.Br J Pharmacol 86:765?775","journal-title":"Br J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-8703(88)90522-4","volume":"115","author":"H Dinh","year":"1988","unstructured":"Dinh H, Baker BJ, de Soyza N, Murphy ML (1988) Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.Am Heart J 115:92?96","journal-title":"Am Heart J"},{"key":"CR12","first-page":"154","volume":"133","author":"F Dressler","year":"1985","unstructured":"Dressler F, Gr\u00e4vinghoff L, Gr\u00fctte E, et al. (1985) Die Behandlung von Herzrhythmusst\u00f6rungen mit Propafenon bei S\u00e4uglingen und Kindern.Monatsschr Kinderheilkd 133:154?157","journal-title":"Monatsschr Kinderheilkd"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/oxfordjournals.eurheartj.a061621","volume":"5","author":"ID Dukes","year":"1984","unstructured":"Dukes ID, Vaughan Williams EM (1984) The multiple modes of action of propafenone.Eur Heart J 5:115?125","journal-title":"Eur Heart J"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","volume":"18","author":"FA Fish","year":"1991","unstructured":"Fish FA, Gillette PC, Benson DW, for the Pediatric Electrophysiology Group (1991) Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide.J Am Coll Cardiol 18:356?365","journal-title":"J Am Coll Cardiol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJM199002223220806","volume":"322","author":"C Funck-Brentano","year":"1990","unstructured":"Funck-Brentano C, Kroemer HK, Lee JT, Roden DM (1990) Propafenone.N Engl J Med 322:518?524","journal-title":"N Engl J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1540-8159.1984.tb05591.x","volume":"7","author":"R Garcia-Civera","year":"1984","unstructured":"Garcia-Civera R, Sanjun R, Morell S, et al. (1984) Effects of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia.PACE Pacing Clin Electrophysiol 7:649?655","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0002-9149(86)90227-4","volume":"1405","author":"A Garson","year":"1986","unstructured":"Garson A (1986) Dosing the newer antiarrhythmic drugs in children: considerations in pediatric pharmacology.Am J Cardiol 1405:1405?1407","journal-title":"Am J Cardiol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/0002-9149(87)90935-0","volume":"59","author":"A Garson","year":"1987","unstructured":"Garson A, Moak JP, Smith RT, Norton JB (1987) Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia.Am J Cardiol 59:1422?1424","journal-title":"Am J Cardiol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0002-8703(91)90467-V","volume":"122","author":"P Guccione","year":"1991","unstructured":"Guccione P, Drago F, Di Donato RM, et al. (1991) Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in mid-term follow-up.Am Heart J 122: 1022?1027","journal-title":"Am Heart J"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0735-1097(90)90251-J","volume":"15","author":"P Guccione","year":"1990","unstructured":"Guccione P, Paul T, Garson A (1990) Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.J Am Coll Cardiol 15: 1118?1124","journal-title":"J Am Coll Cardiol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03189604","volume":"9","author":"HG Hege","year":"1984","unstructured":"Hege HG, Hollmann M, Kaumeier S, Lietz H (1984) The metabolic fate of2H-labelled propafenone in man.Eur J Drug Metab Pharmacokinet 9:41?55","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0002-9149(93)90675-3","volume":"72","author":"J Janousek","year":"1993","unstructured":"Janousek J, Paul T, Reimer A, Kallfelz HC (1993) Usefulness of propafenone for supraventricular arrhythmias in infants and children.Am J Cardiol 72:294?300","journal-title":"Am J Cardiol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/clpt.1987.152","volume":"42","author":"RE Kates","year":"1987","unstructured":"Kates RE, Yee YG, Kirsten EB (1987) Interaction between warfarin and propafenone in healthy young volunteer subjects.Clin Pharmacol Ther 42:305?311","journal-title":"Clin Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"13D","DOI":"10.1016\/S0002-9149(84)80279-9","volume":"54","author":"M Kohlhardt","year":"1984","unstructured":"Kohlhardt M (1984) Block of sodium channels by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle.Am J Cardiol 54:13D-19D","journal-title":"Am J Cardiol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00587856","volume":"396","author":"M Kohlhardt","year":"1983","unstructured":"Kohlhardt M, Seifert C, Hondeghem LM (1983) Tonic and phasic INa blockade by antiarrhythmics: different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivates in mammalian ventricular myocardium.Pflugers Arch 396:199?209","journal-title":"Pflugers Arch"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0002-9149(88)90144-0","volume":"61","author":"K Koike","year":"1988","unstructured":"Koike K, Hesslein PS, Finlay CD, et al. (1988) Atrial automatic tachycardia in children.Am J Cardiol 61:1127?1130","journal-title":"Am J Cardiol"},{"key":"CR27","first-page":"803","volume":"24","author":"WR K\u00fclpmann","year":"1986","unstructured":"K\u00fclpmann WR, Klein H (1986) Gas chromatographic determination of propafenone by use of a ?530 mm? capillary column.J Clin Chem Clin Biochem 24:803?804","journal-title":"J Clin Chem Clin Biochem"},{"key":"CR28","first-page":"103","volume":"1","author":"KP Kunze","year":"1987","unstructured":"Kunze KP, Kentsch M, Kuck KH (1987) Flecainide for treatment of atrial and juctional ectopic tachycardia.J Electrophysiol 1:103?112","journal-title":"J Electrophysiol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0735-1097(86)80233-9","volume":"7","author":"KP Kunze","year":"1986","unstructured":"Kunze KP, Kuck KH, Schl\u00fcter M, Bleifeld W (1986) Effect of encainide and flecainide on chronic ectopic atrial tachycardia.J Am Coll Cardiol 7:1121?1126","journal-title":"J Am Coll Cardiol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9149(90)90810-N","volume":"65","author":"H Lange","year":"1990","unstructured":"Lange H, Lampert S, Sutton J, Lown B (1990) Changes in cardiac output determined by continuous-wave doppler echocardiography during propafenone or mexilitine drug testing.Am J Cardiol 65:458?462","journal-title":"Am J Cardiol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-9149(88)90986-1","volume":"62","author":"PK Lee","year":"1988","unstructured":"Lee PK, Kerr CR, Vorderbrugge S, Qi A, Yeung-Lai-Wah JA (1988) Symptomatic sinus node dysfunction associated with the use of propafenone.Am J Cardiol 62:480?481","journal-title":"Am J Cardiol"},{"key":"CR32","first-page":"1385","volume":"80","author":"V Lucet","year":"1987","unstructured":"Lucet V, Do Ngoc D, Fidelle J, et al. (1987) Efficacite antiarrhythmique de la propafenone chez l'enfant.Arch Mal Coeur Vaiss 80:1385?1393","journal-title":"Arch Mal Coeur Vaiss"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0735-1097(87)80478-3","volume":"9","author":"PL Ludmer","year":"1987","unstructured":"Ludmer PL, McGowan NE, Antman EM, Friedman PL (1987) Efficacy of propafenone on Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term followup.J Am Coll Cardiol 9:1357?1363","journal-title":"J Am Coll Cardiol"},{"key":"CR34","first-page":"419","volume":"246","author":"G Malfatto","year":"1988","unstructured":"Malfatto G, Zaza A, Forster M, et al. (1988) Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.J Pharmacol Exp Ther 246:419?426","journal-title":"J Pharmacol Exp Ther"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9149(85)91017-3","volume":"56","author":"M Manz","year":"1985","unstructured":"Manz M, Steinbeck G, L\u00fcderitz B (1985) Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.Am J Cardiol 56:593?597","journal-title":"Am J Cardiol"},{"key":"CR36","first-page":"461","volume":"228","author":"AA McLeod","year":"1984","unstructured":"McLeod AA, Stiles GL, Shand DG (1984) Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.J Pharmacol Exp Ther 228:461?466","journal-title":"J Pharmacol Exp Ther"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1540-8159.1992.tb05133.x","volume":"15","author":"LJ Miwa","year":"1992","unstructured":"Miwa LJ, Jolson HM (1992) Propafenone associated agranulocytosis.PACE Pacing Clin Electrophysiol 15:387?390","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"CR38","first-page":"37","volume-title":"Pediatric Cardiac Arrhythmias: Electrophysiology and Pacing","author":"JP Moak","year":"1990","unstructured":"Moak JP (1990) Pharmacology and electrophysiology of antiarrhythmic drugs. In: Gillette PC, Garson A (eds)Pediatric Cardiac Arrhythmias: Electrophysiology and Pacing. Saunders, Philadelphia, pp 37?115"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0735-1097(86)80190-5","volume":"8","author":"J Morganroth","year":"1986","unstructured":"Morganroth J, Anderson JL, Gentzkow CD (1986) Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.J Am Coll Cardiol 8:607?615","journal-title":"J Am Coll Cardiol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.78.4.863","volume":"78","author":"B Musto","year":"1988","unstructured":"Musto B, D'Onofrio A, Cavarallo C, Musto A (1988) Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.Circulation 78:863?869","journal-title":"Circulation"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1985.194","volume":"38","author":"K Nakamura","year":"1985","unstructured":"Nakamura K, Goto F, Ray WA, et al. (1985) Interethnic differences in genetic polymorphism of debrisoquine and mephenytoin hydroxylation between Japanese and caucasian populations.Clin Pharmacol Ther 38:402?408","journal-title":"Clin Pharmacol Ther"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/pgmj.60.700.155","volume":"60","author":"AW Nathan","year":"1984","unstructured":"Nathan AW, Bexton RS, Hellestrand KJ, Camm AJ (1984) Fatal ventricular tachycardia in association with propafenone, a new class IC antiarrhythmic agent.Postgrad Med J 60:155?156","journal-title":"Postgrad Med J"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0735-1097(92)90192-P","volume":"20","author":"T Paul","year":"1992","unstructured":"Paul T, Reimer A, Janousek J, Kallfelz HC (1992) Efficacy and safety of propafenone in congenital junctional ectopic tachycardia.J Am Coll Cardiol 20:911?914","journal-title":"J Am Coll Cardiol"},{"key":"CR44","first-page":"482","volume":"81","author":"T Paul","year":"1992","unstructured":"Paul T, Reimer A, Kallfelz HC (1992) Effektivit\u00e4t von Propafenon bei kongenitaler junktionaler ektoper Tachykardie ein Fallbericht.Z Kardiol 81:482?485","journal-title":"Z Kardiol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"38E","DOI":"10.1016\/0002-9149(87)90200-1","volume":"59","author":"PJ Podrid","year":"1987","unstructured":"Podrid PJ, Lampert S, Graboys TB, Blatt CM, Lown B (1987) Aggravation of arrhythmia by antiarrhythmic drugs: incidence and predictors.Am J Cardiol 59:38E-44E","journal-title":"Am J Cardiol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0735-1097(84)80328-9","volume":"4","author":"PJ Podrid","year":"1984","unstructured":"Podrid PJ, Lown B (1984) Propafenone: a new agent for ventricular arrhythmia.J Am Coll Cardiol 4:117?125","journal-title":"J Am Coll Cardiol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.17.2.102","volume":"17","author":"DA Price-Evans","year":"1980","unstructured":"Price-Evans DA, Mahgoub A, Sloan TP, Idle JR, Smith RL (1980) A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.J Med Genet 17:102?105","journal-title":"J Med Genet"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"26D","DOI":"10.1016\/S0002-9149(84)80282-9","volume":"54","author":"EN Prystowsky","year":"1984","unstructured":"Prystowsky EN, Heger JJ, Chilson DA, et al. (1984) Antiarrhythmic and electrophysiologic effects of oral propafenone.Am J Cardiol 54:26D-28D","journal-title":"Am J Cardiol"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1540-8167.1987.tb01451.x","volume":"1","author":"S Ravid","year":"1987","unstructured":"Ravid S, Podrid PJ, Novrit B (1987) Safety of long-term propafenone therapy for cardiac arrhythmia?experience with 774 patients.J Electrophysiol 1:580?590","journal-title":"J Electrophysiol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0002-9149(91)90646-3","volume":"68","author":"A Reimer","year":"1991","unstructured":"Reimer A, Paul T, Kallfelz HC (1991) Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.Am J Cardiol 68:741?744","journal-title":"Am J Cardiol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9149(84)90687-8","volume":"53","author":"DM Salerno","year":"1984","unstructured":"Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M (1984) A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.Am J Cardiol 53:77?83","journal-title":"Am J Cardiol"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0735-1097(84)80190-4","volume":"3","author":"EN Shen","year":"1984","unstructured":"Shen EN, Sung RJ, Morady F (1984) Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.J Am Coll Cardiol 3:1291?1297","journal-title":"J Am Coll Cardiol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"9D","DOI":"10.1016\/S0002-9149(84)80278-7","volume":"54","author":"LA Siddoway","year":"1984","unstructured":"Siddoway LA, Roden DM, Woosley RL (1984) Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations.Am J Cardiol 54:9D-12D","journal-title":"Am J Cardiol"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.75.4.785","volume":"75","author":"LA Siddoway","year":"1987","unstructured":"Siddoway LA, Thompson KA, McAllister CB, et al. (1987) Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.Circulation 75:785?791","journal-title":"Circulation"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1540-8167.1987.tb01442.x","volume":"1","author":"BN Singh","year":"1987","unstructured":"Singh BN (1987) Mechanism of action of antiarrhythmic agents: focus on propafenone.J Electrophysiol 1:503?516","journal-title":"J Electrophysiol"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1540-8167.1987.tb01443.x","volume":"1","author":"NA Smith","year":"1987","unstructured":"Smith NA, Kates RE, Harrison DC (1987) The clinical pharmacology of propafenone.J Electrophysiol 1:517?526","journal-title":"J Electrophysiol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.1985.193","volume":"38","author":"E Steiner","year":"1985","unstructured":"Steiner E, Iselius L, Alvan G, Lindsten J, Sjoqvist F (1985) A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.Clin Pharmacol Ther 38:394?401","journal-title":"Clin Pharmacol Ther"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(85)90144-X","volume":"118","author":"J Tamargo","year":"1985","unstructured":"Tamargo J, Delgado C (1985) Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.Eur J Pharmacol 118:331?340","journal-title":"Eur J Pharmacol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","unstructured":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Eng J Med 321: 406?412","journal-title":"N Eng J Med"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","volume":"327","author":"The Cardiac Arrhythmia Suppression Trial II Investigators","year":"1992","unstructured":"The Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effect of the antiarrhythmic agent morizicine on survival after myocardial infarction.N Engl J Med 327:227?233","journal-title":"N Engl J Med"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9149(88)90657-1","volume":"62","author":"The Encainide-Ventricular Tachycardia Study Group","year":"1988","unstructured":"The Encainide-Ventricular Tachycardia Study Group (1988) Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction.Am J Cardiol 62:571?575","journal-title":"Am J Cardiol"},{"key":"CR62","first-page":"950","volume":"244","author":"KA Thompson","year":"1988","unstructured":"Thompson KA, Iansmith DH, Siddoway LA, Woosley RL, Roden DM (1988) Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.J Pharmacol Exp Ther 244:950?955","journal-title":"J Pharmacol Exp Ther"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/01.CIR.81.5.1544","volume":"81","author":"E Villain","year":"1990","unstructured":"Villain E, Vetter VL, Garcia JM, et al. (1990) Evolving concepts in the management of congenital junctional ectopic tachycardia: a multicenter study.Circulation 81:1544?1549","journal-title":"Circulation"},{"key":"CR64","first-page":"1489","volume":"34","author":"G Philipsborn Von","year":"1984","unstructured":"Von Philipsborn G, Gries J, Hofmann HP, et al. (1984) Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.Arzneimittelforschung 34:1489?1497","journal-title":"Arzneimittelforschung"},{"key":"CR65","first-page":"410","volume":"129","author":"H Weber","year":"1981","unstructured":"Weber H, Eigster G, Wesselhoeft H (1981) Propafenon in der Behandlung von Herzrhythmusst\u00f6rungen im S\u00e4uglings- und Kindesalter.Monatsschr Kinderheilkd 129:410?413","journal-title":"Monatsschr Kinderheilkd"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/hrt.57.2.171","volume":"57","author":"C Wren","year":"1987","unstructured":"Wren C, Campbell RWF (1987) The response of pediatric arrhythmias to intravenous and oral flecainide.Br Heart J 57:171?175","journal-title":"Br Heart J"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/8.suppl_D.25","volume":"8","author":"C Wren","year":"1987","unstructured":"Wren C, Campbell RWF (1987) His bundle tachycardia-arrhythmogenic and antiarrhythmic effects of therapy.Eur Heart J 8:647?650","journal-title":"Eur Heart J"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-3476(05)82900-2","volume":"116","author":"E Zalzstein","year":"1990","unstructured":"Zalzstein E, Koren G, Bryson SM, Freedom RM (1990) Interaction between digoxin and propafenone in children.J Pediatr 116:310?312","journal-title":"J Pediatr"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0002-9149(84)90210-8","volume":"54","author":"RH Zeiler","year":"1984","unstructured":"Zeiler RH, Gough WB, El-Sherif N (1984) Electrophysiologic effects of propafenone on canine ischemic cardiac cells.Am J Cardiol 54:424?429","journal-title":"Am J Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00800674.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00800674\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00800674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T14:20:43Z","timestamp":1556288443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00800674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF00800674"],"URL":"https:\/\/doi.org\/10.1007\/bf00800674","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}